Daisuke Omoto

415 total citations
25 papers, 195 citations indexed

About

Daisuke Omoto is a scholar working on Pharmacology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Daisuke Omoto has authored 25 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Pathology and Forensic Medicine and 6 papers in Dermatology. Recurrent topics in Daisuke Omoto's work include Drug-Induced Adverse Reactions (7 papers), Cutaneous lymphoproliferative disorders research (4 papers) and Autoimmune Bullous Skin Diseases (3 papers). Daisuke Omoto is often cited by papers focused on Drug-Induced Adverse Reactions (7 papers), Cutaneous lymphoproliferative disorders research (4 papers) and Autoimmune Bullous Skin Diseases (3 papers). Daisuke Omoto collaborates with scholars based in Japan, United States and Vietnam. Daisuke Omoto's co-authors include Manabu Yoshioka, Shun Ohmori, Yu Sawada, Motonobu Nakamura, Daisuke Nishio, Takashi Yamaguchi, Etsuko Okada, Chikako Kato, Natsuko Saito‐Sasaki and Yasuko Nagai and has published in prestigious journals such as PLoS ONE, Scientific Reports and British Journal of Cancer.

In The Last Decade

Daisuke Omoto

23 papers receiving 194 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daisuke Omoto Japan 8 46 39 37 37 30 25 195
Jong Keun Seo South Korea 10 77 1.7× 33 0.8× 17 0.5× 48 1.3× 21 0.7× 21 205
Aikaterini Tsiogka Greece 7 94 2.0× 40 1.0× 7 0.2× 32 0.9× 14 0.5× 28 209
Funda Tamer Türkiye 12 143 3.1× 48 1.2× 12 0.3× 38 1.0× 19 0.6× 62 336
Tatyana Gavrilova United States 6 42 0.9× 80 2.1× 7 0.2× 56 1.5× 19 0.6× 13 302
Min Moon Tang Malaysia 9 126 2.7× 54 1.4× 10 0.3× 22 0.6× 24 0.8× 40 337
Bahar Sevimli Dikicier Türkiye 9 114 2.5× 70 1.8× 9 0.2× 15 0.4× 14 0.5× 32 239
Adrian Pona United States 10 176 3.8× 80 2.1× 10 0.3× 30 0.8× 9 0.3× 29 298
Joana Antunes Portugal 6 152 3.3× 115 2.9× 14 0.4× 27 0.7× 24 0.8× 31 274
G Recchia Italy 9 117 2.5× 112 2.9× 33 0.9× 37 1.0× 17 0.6× 11 269
C Mowad United States 6 129 2.8× 85 2.2× 7 0.2× 20 0.5× 12 0.4× 11 219

Countries citing papers authored by Daisuke Omoto

Since Specialization
Citations

This map shows the geographic impact of Daisuke Omoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Omoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Omoto more than expected).

Fields of papers citing papers by Daisuke Omoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Omoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Omoto. The network helps show where Daisuke Omoto may publish in the future.

Co-authorship network of co-authors of Daisuke Omoto

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Omoto. A scholar is included among the top collaborators of Daisuke Omoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Omoto. Daisuke Omoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okada, Etsuko, et al.. (2022). Vedolizumab Attenuates Immune-Checkpoint-Therapy-Induced Infliximab-Refractory Colitis. Diagnostics. 12(2). 480–480. 4 indexed citations
2.
Sawada, Yu, Natsuko Saito‐Sasaki, Shun Ohmori, et al.. (2021). Psoriasis epidemiology screening tool (PEST) is useful for the detection of psoriatic arthritis in the Japanese population. Scientific Reports. 11(1). 16146–16146. 7 indexed citations
3.
Yoshioka, Manabu, Yu Sawada, Natsuko Saito‐Sasaki, et al.. (2021). High S100A2 expression in keratinocytes in patients with drug eruption. Scientific Reports. 11(1). 5493–5493. 17 indexed citations
4.
Sawada, Yu, Natsuko Saito‐Sasaki, Kayo Yamamoto, et al.. (2020). A Retrospective Study of Superficial Type Atypical Lipomatous Tumor. Frontiers in Medicine. 7. 609515–609515. 8 indexed citations
5.
Saito‐Sasaki, Natsuko, Yu Sawada, Shun Ohmori, et al.. (2017). A possible role of IL-23-producing cells in a patient with psoriasiform drug eruption due to tazobactam and piperacillin hydrate: a case study and literature review. European Journal of Dermatology. 27(1). 88–89. 1 indexed citations
6.
Oda, Tomoko, Yu Sawada, Takashi Yamaguchi, et al.. (2017). Psoriatic Erythroderma Caused by Terbinafine: A Possible Pathogenetic Role for IL-23. Journal of Investigational Allergology and Clinical Immunology. 27(1). 63–64. 3 indexed citations
7.
Sawada, Yu, Takashi Yamaguchi, Shun Ohmori, et al.. (2017). Lichenoid drug eruption caused by adalimumab: a case report and literature review. European Journal of Dermatology. 27(1). 69–70. 9 indexed citations
8.
Saito‐Sasaki, Natsuko, Yu Sawada, Shun Ohmori, et al.. (2016). Maculopapular type drug eruption caused by fosphenytoin. European Journal of Dermatology. 26(5). 502–503.
9.
Oda, Tomoko, Yu Sawada, Shun Ohmori, et al.. (2016). Fixed drug eruption-like macules caused by febuxostat. European Journal of Dermatology. 26(4). 412–413. 3 indexed citations
10.
Sawada, Yu, Shun Ohmori, Daisuke Omoto, et al.. (2016). Lichenoid Drug Eruption Caused by Limaprost Alfadex. Acta Dermato Venereologica. 96(7). 997–998. 3 indexed citations
11.
Oda, Tomoko, Yu Sawada, Takashi Yamaguchi, et al.. (2016). Calciphylaxis following acute renal injury: a case and literature review. SpringerPlus. 5(1). 1043–1043. 2 indexed citations
12.
Hamada, Kaoru, Yu Sawada, Takashi Yamaguchi, et al.. (2016). Photosensitivity due to tocilizumab presenting with erythema multiforme-like lesions. European Journal of Dermatology. 26(5). 503–504. 6 indexed citations
13.
Sawada, Yu, Shun Ohmori, Daisuke Omoto, et al.. (2016). Erythema papulosa semicircularis recidivans associated with primary pancreas B cell lymphoma. European Journal of Dermatology. 26(3). 306–307. 4 indexed citations
14.
Sakuragi, Yumiko, Takashi Yamaguchi, Yoko Hara, et al.. (2016). Dome-shaped metastatic lesion on the scalp from a uterine smooth muscle tumor of uncertain malignant potential (STUMP). European Journal of Dermatology. 26(2). 193–194. 3 indexed citations
15.
Saito‐Sasaki, Natsuko, Yu Sawada, Shun Ohmori, et al.. (2016). Anaphylactoid purpura triggered by cellulitis as a favorable prognosis: case report and literature review. SpringerPlus. 5(1). 1112–1112. 1 indexed citations
16.
Sawada, Yu, Shun Ohmori, Daisuke Omoto, et al.. (2015). CD30-positive Cutaneous Pseudolymphoma Caused by Tocilizumab in a Patient with Rheumatoid Arthritis: Case Report and Literature Review. Acta Dermato Venereologica. 96(4). 570–571. 16 indexed citations
17.
Nakamura, Motonobu, Takashi Yamaguchi, Yoko Hara, et al.. (2015). Nivolumab in the treatment of malignant melanoma: review of the literature. OncoTargets and Therapy. 8. 2045–2045. 29 indexed citations
18.
Sakuragi, Yumiko, Yu Sawada, Yoko Hara, et al.. (2015). Acute Generalized Exanthematous Pustulosis Caused by Faropenem: A Possible Pathogenetic Role for Interleukin-23. Acta Dermato Venereologica. 96(2). 265–266. 12 indexed citations
19.
Kuwahara, Keisuke, Teppei Imai, Akiko Nishihara, et al.. (2014). Overtime Work and Prevalence of Diabetes in Japanese Employees: Japan Epidemiology Collaboration on Occupational Health Study. PLoS ONE. 9(5). e95732–e95732. 16 indexed citations
20.
Iinuma, H., Junko Tamura, Daisuke Omoto, et al.. (2012). Accurate and rapid novel genetic diagnosis for detection of sentinel lymph node metastasis in breast cancer patients. British Journal of Cancer. 107(4). 724–731. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jong Keun Seo Breakdown of academic impact, for papers by Aikaterini Tsiogka Breakdown of academic impact, for papers by Funda Tamer Breakdown of academic impact, for papers by Tatyana Gavrilova Breakdown of academic impact, for papers by Min Moon Tang Breakdown of academic impact, for papers by Bahar Sevimli Dikicier Breakdown of academic impact, for papers by Adrian Pona Breakdown of academic impact, for papers by Joana Antunes Breakdown of academic impact, for papers by G Recchia Breakdown of academic impact, for papers by C Mowad
Rankless by CCL
2026